Table 1 Participants’ demographic and clinical characteristics
Participants (n = 23) |  |
|---|---|
Age, years: mean (s.d.) range | 43 (10) 25–58 |
Male: n (%) | 16 (70) |
Employment, n (%) | |
 Employed, full/part-time | 3 (13) |
 Unemployed/DLA or incapacity benefit | 20 (87) |
Ethnicity, n (%) | |
 British, White | 11 (48) |
 British, Carribean | 7 (30) |
 British, mixed | 1 (5) |
 Other | 4 (17) |
Location of recruitment, n (%) | |
 Community mental health teams | 22 (96) |
 Specialist mood disorders clinic | 1 (4) |
Diagnosis received, n (%) | |
 Schizophrenia | 20 (87) |
 Schizoaffective disorder | 2 (8) |
 Bipolar II disorder | 1 (4) |
Medication Taken, n (%) | |
 Clozapine | 11 (47) |
 Paliperidone | 4 (17) |
 Risperidone | 3 (13) |
 Aripiprazole | 2 (9) |
 Olanzapine | 1 (4) |
 Quetiapine | 1 (4) |
 Chlorpromazine | 1 (4) |
 Amisulpride | 1 (4) |
 Citalopram | 2 (8) |
 Metformin | 1 (4) |
 Bendroflumethiazide | 1 (4) |
 Procyclidine | 1 (4) |
 Atorvastatin | 1 (4) |
 Zopiclone | 1 (4) |
 Clonazepam | 1 (4) |